Davide Komla Ebri, PhD, is currently Research Associate for the Molecular Endocrinology Laboratory at Imperial College London. Since 2016 he has been working under the supervision of Prof. Graham Williams and Prof. Duncan Bassett on basic science projects related to skeletal biology. The main subjects of his research in London are the genetics of osteoporosis and osteoarthritis, and the effects of thyroid hormone on bone establishment and repair. In 2012 he obtained a double master degree in Molecular Cell Biology and Genetics with full marks jointly from Università degli Studi di Milano in Italy and Université Denis Diderot in Paris, France. The research project for his master diploma consisted in the evaluation of the efficacy of FGFR3 tyrosine kinase inhibitors. This project, supervised by Dr Laurence Legeai-Mallet, will lead him to achieve a PhD scholarship granted by Université René Descartes to develop a novel therapeutic approach for achondroplasia based on Infigratinib administration. In 2016, he successfully completed his PhD in Genetics in Paris and moved to London.